Division of Pulmonary, Critical Care and Sleep Medicine, University of Texas Health Science Center at Houston, 6431 Fannin St., MSB 1.274, Houston, TX 77030, USA.
J Clin Sleep Med. 2009 Apr 15;5(2):137-44.
Determine whether treatment of sleep disorders identified in brain injured adults would result in resolution of those sleep disorders and improvement of symptoms and daytime function.
Prospective evaluation of unselected traumatic brain injury patients with nocturnal polysomnography (NPSG), multiple sleep latency test (MSLT), Epworth Sleepiness Scale (ESS), and neuropsychological testing including Psychomotor Vigilance Test (PVT), Profile of Mood States (POMS), and Functional Outcome of Sleep Questionnaire (FOSQ) before and after treatment with continuous positive airway pressure (CPAP) for obstructive sleep apnea (OSA), modafinil (200 mg) for narcolepsy and posttraumatic hypersomnia (PTH), or pramipexole (0.375 mg) for periodic limb movements in sleep (PLMS).
Three academic medical centers.
Fifty-seven (57) adults > or = 3 months post traumatic brain injury (TBI).
Abnormal sleep studies were found in 22 subjects (39%), of whom 13 (23%) had OSA, 2 (3%) had PTH, 3 (5%) had narcolepsy, 4 (7%) had PLMS, and 12 had objective excessive daytime sleepiness with MSLT score < 10 minutes. Apneas, hypopneas, and snoring were eliminated by CPAP in OSA subjects, but there was no significant change in MSLT scores. Periodic limb movements were eliminated with pramipexole. One of 3 narcolepsy subjects and 1 of 2 PTH subjects had resolution of hypersomnia with modafinil. There was no significant change in FOSQ, POMS, or PVT results after treatment.
Treatment of sleep disorders after TBI may result in polysomnographic resolution without change in sleepiness or neuropsychological function.
确定治疗脑损伤成年人的睡眠障碍是否会导致这些睡眠障碍的解决,并改善症状和白天功能。
对未经选择的创伤性脑损伤患者进行前瞻性评估,这些患者进行了夜间多导睡眠图(NPSG)、多次睡眠潜伏期试验(MSLT)、Epworth 嗜睡量表(ESS)以及神经心理学测试,包括精神运动警觉测试(PVT)、心境状态问卷(POMS)和睡眠功能问卷(FOSQ),然后对这些患者进行持续气道正压通气(CPAP)治疗阻塞性睡眠呼吸暂停(OSA)、莫达非尼(200mg)治疗创伤后过度嗜睡(PTH)或普拉克索(0.375mg)治疗睡眠周期性肢体运动(PLMS)。
三个学术医疗中心。
57 名(57)年龄>或=3 个月的创伤性脑损伤(TBI)成年人。
22 名(39%)受试者存在异常睡眠研究,其中 13 名(23%)患有 OSA,2 名(3%)患有 PTH,3 名(5%)患有发作性睡病,4 名(7%)患有 PLMS,12 名(21%)有客观的日间过度嗜睡,MSLT 评分<10 分钟。CPAP 消除了 OSA 患者的呼吸暂停、低通气和打鼾,但 MSLT 评分无显著变化。普拉克索消除了周期性肢体运动。莫达非尼治疗后,3 名发作性睡病患者中的 1 名和 2 名 PTH 患者中的 1 名嗜睡症状得到缓解。治疗后 FOSQ、POMS 或 PVT 结果无明显变化。
TBI 后治疗睡眠障碍可能会导致多导睡眠图得到解决,而不会改变嗜睡或神经心理学功能。